Fast Track Your Health-Tech Startup: The Journey of OneStart Finalist, BeamLine

Diagnostics

1.14M biopsy procedures per year2-3 weeks for diagnosisCosting £740M per year

Only 10% of patients require treatment

90% of time is spent diagnosing healthy patients costing £563M of £740M

Patent-pending data analysis method

+ =Commercially

available deviceBeamLine Illuminare

97% sensitivity for pre-cancerous detection

Instant diagnosis saving £515M per year

We save health care providers

TimeInstant

Resources90%

reduction

Money70% lower

cost

Patient peace of mind & immediate treatment

Immeasurable

2011 F

ebM

arA

prM

ayJ

unJ

ulA

ug

Company founded

2015

PhD research

Manufacturing deal

negotiationOrganise

clinical trial expansion

Partnership with NTW NHS trust

£50k seed capital

Class of 2016

200 patient clinical trial

Sep

Europe finalists

iStart USsemi-

finalists

2015 Top 50 Movers

and Shakers in

biobusiness

Prof. Oyvind Bruland

Journey

Fundraising

£1.3M

Seed£1.3M

£46.4K Pre-seed £10M

Series A

Market ready pre-oesphageal cancer diagnostic system

Expansion to whole

gastrointestinal tract

Our Team

Dr. Liberty ForemanClinical data analyst

Prof. Laurence LovatGastroenterologist at

UCLH.

Dr. Will West President at CTS inc.

Dr. Katherine OliverTechnical expert

CSO & Co-founder

Caroline PottsHead of R&D at

NIHR NTW.

CEO & Co-founder

Medical advisor Commercial advisor

Clinical trials co-ordinator

Prof. Tom FearnHead of Statistics at

UCL

Statistical advisor

CTO

RecruitingSenior software

engineer

Over 60 years combined experience with translational medicine

Chairman

RecruitingDiagnostic devices expert

Simple · Accurate · Universal